Dimebolin

Type: Keyphrase

Name: Dimebolin

First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents

Medivation's Pact On One Drug May Help Insure Another

MedivationThe deal gives Medivation insurance as it develops its Alzheimer's drug Dimebon, says analyst Elemer Piros of Rodman & Renshaw. Both Dimebon and the prostate cancer drug, called MDV3100, could revolutionize their respective markets, he says ... [Investors Business Daily - 11/20/2009]

Entities: MDV3100, Dimebolin, Prostate Cancer

First Reported 11/03/2009 - Updated 11/03/2009 - 5 Documents (in Health)

Pfizer Inc

Pfizer, Medivation Initiate Two Phase 3 Trials Of Dimebon In Alzheimer's Patients - Update

This Virtual Directory does not allow contents to be listed. ... [RTTNews.com - 11/03/2009]

Entities: Dimebolin, Alzheimer's Disease, Pfizer Inc

First Reported 11/01/2009 - Updated 11/01/2009 - 2 Documents (in Health)

This Week in Biotech: More Treats than Tricks

Now that the markets have strengthened, the company hopes to raise an estimated $80.5 million in an initial public offering to fund a phase 3 trial of its most advanced therapy for the treatment of critical limb ischemia, which can happen when a limb ... [Seeking Alpha - 11/01/2009]

Entities: MDV3100, Antibody, Biotechnology

First Reported 10/27/2009 - Updated 10/27/2009 - 1 Documents

Astellas Pharma Inc

Medivation Partners With Astellas For Prostate Cancer Drug

NEW YORK -(Dow Jones)- Medivation Inc. (MDVN) signed a global partnership with Japanese pharmaceutical company Astellas Pharma Inc. (ALPMY) to develop and market the San Francisco company's experimental prostate cancer treatment.Medivation will receive ... [Nasdaq - 10/27/2009]

Entities: MediVation Inc, Prostate Cancer, MDV3100, Dimebolin, Astellas Pharma Inc

First Reported 10/30/2009 - Updated 10/30/2009 - 1 Documents (in Biology)

Food and Drug Administration

Adjust-as-You-Go Trial Approach: Key to Pleasing FDA, Partners?

Such was the subject of a roundtable during the second day of the BIO Investor Forum here. Wrapping up two days before Halloween, the conference delved into a variety of challenges that haunt the industry, not the least of which involves methods of putting ... [Pharmacy Choice - 10/30/2009]

Entities: Food and Drug Administration, MDV3100, GenVec, Inc.

First Reported 11/06/2009 - Updated 11/06/2009 - 1 Documents (in Health)

Pfizer and Medivation Initiate Two Phase 3 Trials of Dimebon

Pfizer Inc (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) announced the initiation of CONTACT and CONSTELLATION, two Phase 3 trials of the investigational drug dimebon (latrepirdine)* in patients with moderate-to-severe Alzheimer's disease (AD).The CONTACT ... [World Pharma News - 11/06/2009]

Entities: Alzheimer's Disease, Pfizer Inc, Dimebolin, MediVation Inc

First Reported 11/05/2009 - Updated 11/05/2009 - 1 Documents

Market Report -- Short Stories (MDVN)

Medivation upgraded to Buy at Roth Capital; tgt raised to $34 . Roth Capital upgrades MDVN to Buy from Hold and raises their tgt to $34 from $21 noting since Phase 2 clinical data on Dimebon, from a study carried out in Russia, were released there has ... [Briefing.com via MSN Money - 11/05/2009]

Entities: Dimebolin, PHASE 2, MDV3100, Short Interest, clinical study

Quotes

"Both could be blockbusters with sales over $1 billion a year" said Piros, who rates the stock outperform, or buy. He says Dimebon has the potential to see sales of $3 billion to $4 billion

Medivation's Pact On One Drug May Help Insure Another [Investors Business Daily - 11/20/2009]

More Content

sort by: Date \| Relevance
Medivation's Pact On One Drug May Help Insure A... [Investors Business Daily - 11/20/2009]
Research and Markets: Dealmaking and Industry O... [Forbes.com - 11/16/2009]
Reuters Summit-Pfizer says absorbing Wyeth at t... [Forbes.com - 11/11/2009]
Pfizer and Medivation Initiate Two Phase 3 Tria... [World Pharma News - 11/06/2009]
Market Report -- Short Stories (MDVN) [Briefing.com via MSN Money - 11/05/2009]
www.PicksThatMove.com: "Picks that move&qu... [TMC Net - 11/04/2009]
Pfizer, Medivation Initiate Two Phase 3 Trials ... [RTTNews.com - 11/03/2009]
Pfizer And Medivation Initiate Two Phase 3 Tria... [Individual.com - 11/03/2009]
Pfizer, Medivation Initiate 2 Phase 3 Trials Of... [RTTNews.com - 11/03/2009]
Pfizer (PFE) And Medivation (MDVN) Initiate Two... [Street Insider - 11/03/2009]
Pfizer And Medivation Initiate Two Phase 3 Tria... [Business Wire - 11/03/2009]
This Week in Biotech: More Treats than Tricks [Seeking Alpha - 11/01/2009]
Adjust-as-You-Go Trial Approach: Key to Pleasin... [Pharmacy Choice - 10/30/2009]
Medivation Partners With Astellas For Prostate ... [Nasdaq - 10/27/2009]
Pfizer, Inc. Q3 2009 Earnings Call Transcript [Seeking Alpha - 10/20/2009]

Log in to Silobreaker

Advanced Search Options

Dimebolin